Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Jul 14;17(7):e0271233. doi: 10.1371/journal.pone.0271233

Appropriateness of indirect markers of muscle damage following lower limbs eccentric-biased exercises: A systematic review with meta-analysis

Emeric Chalchat 1,2,*, Anne-Fleur Gaston 3, Keyne Charlot 1,4, Luis Peñailillo 5, Omar Valdés 6, Pierre-Emmanuel Tardo-Dino 1,4, Kazunori Nosaka 7, Vincent Martin 2,8, Sebastian Garcia-Vicencio 1,4,#, Julien Siracusa 1,4,#
Editor: Xin Ye9
PMCID: PMC9282447  PMID: 35834532

Abstract

Purpose

The aim of this review was to (1) characterize the time-course of markers of exercise-induced muscle damage (EIMD) based on the level of maximal voluntary contraction torque loss at 24-48h post-exercise (MVCloss24-48h), (2) identify factors (e.g., exercise and population characteristics) affecting the level of MVCloss24-48h, and (3) evaluate the appropriateness of EIMD markers as indicators of MVCloss24-48h.

Methods

Magnitude of change of each EIMD markers was normalized using the standardized mean differences method to compare the results from different studies. Time-course of EIMD markers were characterized according to three levels of MVCloss24-48h based on a clustering analysis of the 141 studies included. Association between MVCloss24-48h levels and participant´s characteristics or exercise type/modalities were assessed. Meta-regressions were performed to investigate the associations between MVCloss24-48h and EIMD markers changes at <6h, 24h, 48h, 72h and >96h after exercise.

Results

Time-course of EIMD markers recovery differs between levels of MVCloss24-48h. Training status and exercise type/modality were associated with MVCloss24-48h level (p<0.05). MVCloss24-48h was correlated to changes in myoglobin concentration (<6h), jump height (24h) and range of motion (48h) (p<0.001).

Conclusion

As the exercise could differently affect markers as function of the EIMD severity (i.e., MVCloss24-48h levels), different markers should be used as function of the timing of measurement. Mb concentration should be used during the first hours after the exercise (<6h), whereas jump height (24h) and range of motion (48h) could be used as surrogate for maximal voluntary contraction later. Moreover, training status and exercise type/modality could influence the magnitude of MVCloss24-48h.

Introduction

Eccentric biased exercise − where muscles are activated while lengthening − has received considerable interest in the field of health and sports sciences over the last decades. The use of progressive eccentric exercise has been proposed for the treatment of a variety of chronic diseases such as tendinopathies [1], coronary artery disease [2], knee osteoarthritis [3] or for the preservation of muscle mass in chronic obstructive pulmonary disease patients [4]. The implementation of eccentric contractions as a part of resistance training program has also been shown to be beneficial for the improvement of athletic performance through gain of muscle mass, strength, and power [57] and useful as an injury prevention/rehabilitation strategy [8]. Despite the benefits of this type of exercise, lengthening contractions can alter the ultrastructure of the muscle tissue and induce exercise-induced muscle damage (EIMD) [9].

EIMD is characterized by a prolonged reduction of muscle force and power production which has shown to better represent magnitude of muscle damage when assessed at 24-48h after exercise [10, 11]. The reduction in muscle function is often accompanied by other indirect markers of muscle damage, which have traditionally been used to quantify magnitude of EIMD that can last from few days to several weeks following exercise. Among indirect markers of muscle damage, the delayed-onset muscle soreness (DOMS), decreased joint range of motion (ROM) as well as increased blood levels of circulating muscle proteins such as creatine kinase (CK) and myoglobin (Mb) are the most frequently reported [10]. These EIMD markers are often measured concomitantly to describe a complex succession of events encompassing several physiological processes such as loss of myofibrillar integrity, connective tissue damage, membrane damage, failure in excitation-contraction coupling, and extracellular matrix remodeling [911].

Warren et al. [10], within the limitations of a narrative review approach, published recommendations in which the measurement of muscle strength (i.e., maximal voluntary contraction torque) was raised as the best indirect assessment of the magnitude of EIMD compared to other indirect markers due to its reliability, low cost, accessibility and easy to use [12]. Maximal voluntary contraction (MVC) torque comes closest to evaluating the overall functional contractile capacity of the muscle then has become a great tool in rehabilitation healthcare [12]. Despite the high set of indirect markers reported to assess muscle damage, their usefulness to quantify the magnitude and time-course of EIMD is still under debate, as their responses do not always converge. Since then, numerous studies highlighted an important variability of EIMD markers both in magnitude and time-course, which has limited the interpretation of such changes [11, 13]. Furthermore, as it has already been pointed [11, 13], the discrepancies between markers responses may be partly explained by an important inter-individual variability (age, sex, training status, etc.), the limited sample size, nature of exercise, and muscle groups involved in exercise. Interestingly, a comprehensive synthesis using a systematic and quantitative approach has not been yet performed, making difficult the decision of what is (are) the best marker(s) to monitor EIMD. The evaluation of the appropriateness of the most reported indirect markers of EIMD could be helpful in a sport context to prevent other-related musculoskeletal injuries (e.g., primary lower extremity injury) in the days following the exercise. Furthermore, EIMD is not desired when a clinical population is performing exercise to improve health and adhesion and enjoyment are highly desired to induce long-lasting changes in patients. In this context, it may be of great interest to quantitatively summarize exercise parameters and population characteristics that could influence the magnitude and time course indirect markers of EIMD.

In an attempt to shed light in the complexity, we performed a systematic review and a meta-analysis with the aim to characterize the magnitude and time-course of commonly used indirect markers of EIMD over different levels of muscle function loss at 24–48 h post-exercise (based on the effect size values) by using a classification analysis (clustering) as previously suggested by Damas et al. [13]. The second aim was to identify factors such as exercise parameters and population characteristics affecting the magnitude of muscle strength loss after exercise. Finally, we aimed to evaluate the appropriateness of EIMD markers as indicators of muscle functional deficit.

Materials and methods

Literature search

Five databases including Pubmed, Embase, Web of Science, Cochrane and Scopus were searched using the following terms: (“muscle damage” OR “muscle injury” OR “EIMD”) AND (contraction OR exercise) AND (strength OR MVC OR torque OR force OR “muscle function” OR “neuromuscular function” OR “maximal voluntary contraction”) NOT (“mouse” OR “Mice” OR “rat” OR “animal”) for “English-language” papers from start of records until 29/10/2021. In addition, the literature search was completed with SPORTDiscus that contains theses and dissertations and thereby included “gray literature” (i.e., literature that is difficult to locate or retrieve [14]). This led to the identification of 4,897 potential studies for the initial inclusion for this study (Fig 1). The review was not registered and all necessary information is provided in the present manuscript.

Fig 1. Schematic flowchart of study selection from initial search to the final study inclusion.

Fig 1

Selection criteria

After removing 2,688 duplicates, the titles and abstracts of 2,209 articles were screened using the online program Abstrackr (URL. http://abstrackr.cebm.brown.edu/), an open-source tool for systematic reviews [15]. Among the 2,209 abstracts, 1,473 articles were excluded in the first screening based on the criteria listed below, narrowing the number down to 736 articles for full-text review. Studies were eligible for inclusion if they met the following criteria: (1) they implemented a model to study EIMD of the lower limbs muscles in healthy adults (18–65 years); (2) the outcome measures included isometric and dynamic articular joint torque using an isokinetic dynamometer or load cell force measurement at least two time points (before and 24 or 48 h after exercise) combined with the evaluation of at least one other indirect marker of EIMD (e.g., CK, ROM, DOMS); (3) they did not use recovery techniques or other interventions (e.g., massage, icing, nutritional supplementation); and (4) they reported all necessary data to calculate standardized mean differences (SMD) (i.e., absolute value, standard deviation and sample size). Studies were excluded if they presented duplicated data from a previous publication. The present study protocol followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statements [16]. The exclusion criteria are displayed in Fig 1.

Data collection and quality assessment

Included studies (n = 141) were randomly distributed to nine reviewers and data were independently extracted from text or tables using a standardized assessment spreadsheet. The following criteria were collected: sample size, sex, age, training level, exercise type, MVC torque and other indirect markers of EIMD values at all available time points. When incomplete or missing data were found, the corresponding authors of the studies were contacted or the required data was extrapolated from figures using ImageJ software (v1.51j8; [17]). Only EIMD markers present in at least five studies were included in the analysis: jump height, ROM, DOMS assessed actively and passively, pain pressure threshold (PPT), limb circumference, mechanical response to peripheral stimulation (evoked torque response), rate of torque development (RTD), voluntary activation level (VAL), CK, Mb, lactate dehydrogenase (LDH), interleukin-6 (IL-6), and transverse relaxation time (T2) in magnetic resonance imaging (MRI). Due to the large number of studies assessing DOMS using several different methods, they were classified for “active DOMS” (i.e., during a movement), “passive DOMS” (i.e., without movement) and PPT. The quality of the included manuscripts was assessed by the same nine reviewers based on an adapted checklist proposed by Downs & Black [18] (Fig 2; S1 Data).

Fig 2.

Fig 2

Summary of included experimental groups with forest plot for low (a), moderate (b) and high (c) clusters. QA: Quality assessment; EIMD: exercise-induced muscle damage; Sed: Sedentary; Act: Active; Train: trained;?: unknown; ECCiso: eccentric contractions using an isokinetic ergometer; Plyo: Plyometric exercise; Resist: Eccentric/resistance exercises; DW/R: downhill walking/running; Prol: prolonged aerobic exercise; NM-ES: Neuromuscular electrostimulation; CK: creatine kinase; DOMS: delayed-onset muscle damage; Mb: myoglobin; ROM: range of motion; JH: jump height; EV: evoked response; PPT: pain pressure threshold; VAL: voluntary activation level; LDH: lactate dehydrogenase; RTD: rate of torque development; LC: limb circumference; IL-6: iterleukin-6; T2: transverse relaxation time. “n” represents the number of participants of the experimental group. Data are displayed as standard mean difference (SMD) ± standard error.

Coding for studies

The following moderators were coded: sex (male, female, or both), training status based on the training volume (sedentary, active, trained), exercise modality (eccentric contractions using an isokinetic dynamometer, eccentric/resistance exercise, plyometric exercise, prolonged aerobic exercise, downhill walking/running, neuromuscular electrostimulation, and others) and exercise type (monoarticular, polyarticular). Polyarticular exercises refer to exercises involving movement at multiple joints. Training volume was coded as follow: sedentary (no exercise), active (> 0 h/week and < 3 h/week), and trained (> 3 h/week) based on information available on the articles. The time points of measurements were also coded (<6, 24, 48, 72, >96 h). Early measurements (i.e., between 0 and 6 h) were grouped as “<6 h”, due to the lack of consistencies in the literature to assess “post-exercise” EIMD markers. In the same way, the delayed measurements assessed between 96 to 168 h were grouped as “> 96 h” due to the relatively small number of assessments at these time points. Each moderator and time points were coded by two independent reviewers. Any disagreement between reviewers was discussed in a consensus meeting, and unresolved items were addressed by a third reviewer for resolution.

Statistical analyses

For all analyses, the statistical significance level was set at p < 0.05. SMD [19] (also called “effect size” [20]) and standard error (SE) of MVC torque and other indirect markers of EIMD were calculated for each experimental group at several time points of the measurements. The SMD measure can be used to compare the magnitude of changes of similarly computed measures between studies. Indeed, variable changes between studies cannot be simply compared because these studies may differ in their scales/units of measurement or in their standards for precision of measurement [20]. SMDs were weighted by the inverse of the variance to calculate the overall effect and SE. SMD was calculated as follows:

SMD=MeanTPMeanPREPooledSD

where TP was the value at the time-point of interest, PRE was the baseline value and SD was the standard deviation. Pooled SD was calculated as follows:

PooledSD=(NTP1)VARIANCETP+(NPRE1)VARIANCEPRE(NTP1)+(NPRE1)

where N was the number of participants.

Cohen’s criteria were used to interpret the magnitude of the absolute SMD: <|0.50|: small;|0.50| to |0.80|: moderate; and >|0.80|: large [21]. All calculations were carried out with Comprehensive Meta-analysis software (http://www.meta-analysis.com).

A single composite SMD was calculated to estimate the overall effect of changes in MVC torque and other indirect markers at each time point (<6, 24, 48, 72, >96 h) [22]. A random-effects model was used because the effect of indirect markers might differ according to the type of exercise, training status, sex or other moderators. This analysis was performed in order to describe the time-course of each indirect marker in response to exercise. Changes from baseline (SMD) were considered as significant when 0 was not included in the 95% confidence interval. Similarly, SMD values were significantly different when no overlap was shown between the 95% confidence intervals of the clusters.

A k-medoids clustering (Partitioning around medoids) was done using R (R Core Team; 2020. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org) and the optimal number of clusters was determined using the NbClust R [23]. The script used to perform the analysis is available at: https://github.com/SirJul/Chalchat-2022—Meta-analysis. This clustering analysis was used to classify 141 experimental groups into 3 categories (clusters) based on the largest reduction in SMD torque at 24–48 h post-exercise (MVCloss 24-48h) of each group. Thus, experimental groups were classified as low responders (cluster 1; LOW), moderate responders (cluster 2; MOD) and high responders (cluster 3; HIGH) according to the magnitude of MVCloss 24-48h (i.e., SMD). Once allocated in the clusters, their respective overall effect (i.e., SMD) in MVC torque and others EIMD markers were calculated at each time point (<6, 24, 48, 72, >96 h) using a random-effects model, in order to characterize the magnitude and time-course of commonly used indirect markers of EIMD over different levels of muscle function loss. Positive and negative SMD correspond to an increase and a decrease of indirect markers of EIMD after exercise, respectively. The SMD for each cluster was not calculated for PPT, limb circumference, VAL, RTD, LDH, IL-6 and T2, due to the lack of experimental groups in at least one cluster.

A Chi-square test of association was performed using Jamovi (The jamovi project (2020). jamovi (Version 1.2) [Computer Software]. Retrieved from https://www.jamovi.org, Sydney, Australia) to investigate the relationship between the level of MVCloss 24-48h (clusters) and the characteristics of participants and exercises (age, sex, training status, exercise type/modality, and muscles involved) represented by the distribution (frequencies) into each cluster (Table 1).

Table 1. LOW, MOD and HIGH clusters’ characteristics.

Distribution of training status (a), exercise modality (b) and exercise type (c). Data are expressed in percentage of total participants (%). Expected values corresponds to the distribution of each characteristic in the whole sample. ECCiso: eccentric contractions using an isokinetic ergometer; Plyo: Plyometric exercise; Resist: eccentric/resistance exercises; DW/R: downhill walking/running; Prol: prolonged aerobic exercise; NM-ES: Neuromuscular electrostimulation. Any significant association between clusters and characteristics are displayed (*: p < 0.05; **: p < 0.01).

(a) Cluster* LOW MOD HIGH Expected
Sedentary 20.0% 26.9% 35.9% 26.9%
Active 30.0% 46.2% 33.4% 36.9%
Trained 44.0% 19.2% 17.9% 27.7%
Unknown 6.0% 7.7% 12.8% 8.5%
Total 100% 100% 100% 100%
(b) Cluster** LOW MOD HIGH Expected
ECCiso 22.0% 38.5% 56.4% 37.6%
Plyo 20.0% 5.8% 10.3% 12.0%
Resist 16.0% 38.5% 10.3% 22.7%
DW/R 20.0% 7.7% 18.0% 14.9%
Prol 8.0% 3.8% 0.0% 4.3%
NM-ES 0.0% 1.9% 2.5% 1.4%
Other 14.0% 3.8% 2.5% 7.1%
Total 100% 100% 100% 100%
(c) Cluster** LOW MOD HIGH Expected
Polyarticular 76.0% 42.3% 35.9% 52.5%
Monoarticular 24.0% 57.7% 64.1% 47.5%
Total 100% 100% 100% 100%

Meta-regressions were performed using Comprehensive Meta-analysis software to investigate the association between the changes in MVCloss 24-48h and changes in indirect markers at each time-point (<6, 24, 48, 72, >96 h) (Table 2). A correlation between MVCloss 24-48h and an EIMD marker measured within 6 h post-exercise indicates that this marker could partly predict the MVCloss 24-48h, whereas a correlation between MVCloss 24-48h and an EIMD marker measured between 24 h and 48 h indicates that this marker could be used as a surrogate at these time points. Moreover, correlation between MVCloss 24-48h and an EIMD marker measured later than 48 h post-exercise indicates that this marker is able to retrospectively estimate MVCloss 24-48h.

Table 2. Coefficient of determination (r2) and p-value of meta-regressions between peak reductions in maximal voluntary contraction (MVC) torque and changes in jump height, range of motion, active DOMS, passive DOMS, pain pressure threshold (PPT), limb circumference, evoked response, rate of torque development (RTD), voluntary activation level (VAL), creatine kinase (CK), myoglobin (Mb), lactate dehydrogenase (LDH), interleukin-6 (IL-6) and transverse relaxation time (T2).

“n” represents the number of studies included in the analysis. Results with a P-value < 0.05 are considered significant and are displayed in bold characters.

Time <6h 24h 48h 72h >96h
  r2 p n r2 p n r2 p n r2 p n r2 p n
Jump Height 0.21 <0.001 16 0.40 <0.001 19 0.00 0.21 17 0.07 <0.001 13 - - -
Range of motion 0.23 0.01 12 0.00 0.36 16 0.52 <0.001 16 0.02 0.23 12 0.00 0.41 8
Active DOMS 0.03 0.02 45 0.00 0.55 68 0.13 <0.001 76 0.16 <0.001 48 0.28 <0.001 27
Passive DOMS 0.00 0.13 26 0.00 0.71 32 0.16 <0.001 40 0.22 0.02 23 0.00 0.16 10
PPT 0.17 0.24 6 0.13 0.02 8 0.05 0.09 11 0.10 0.02 6 0.00 0.35 7
Circumference 1.00 <0.001 4 0.78 <0.001 7 0.82 0.01 8 0.76 0.01 7 0.31 0.08 4
Evoked response 0.00 0.16 15 0.88 <0.001 11 0.91 <0.001 13 0.98 <0.001 8 1.00 <0.001 8
RTD 0.04 0.36 10 0.51 0.02 8 0.00 0.42 9 - - - 0.95 <0.001 5
VAL 0.32 0.04 10 0.29 0.29 7 0.00 0.42 10 0.70 <0.001 5 0.00 0.83 7
CK 0.02 0.08 37 0.00 0.39 73 0.00 0.61 80 0.21 <0.001 49 0.00 0.19 33
Mb 0.47 <0.001 15 0.00 0.26 15 0.09 0.30 16 0.00 0.14 10 0.00 0.93 7
LDH 0.00 0.52 6 0.00 0.40 8 0.00 0.52 8 0.00 0.77 7 - - -
IL-6 0.00 0.46 5 0.00 0.62 5 0.46 0.13 5 - - - - - -
T2 - - - 1.00 <0.001 5 1.00 <0.001 6 1.00 0.10 4 - - -

Results

Identified studies: Characteristics and classification into clusters

A total of 3,089 participants (24.1 ± 3.5 years old) were computed from the included studies (n = 141). The results of the quality assessment of the included studies is provided in Fig 2 and S1 Data. Among them, 81% were males and 19% were females. The participants were classified in four training status categories: sedentary (26.9%), active (36.9%), trained (27.7%), and unknown (8.5%). The participants performed different exercises including eccentric contractions using an isokinetic dynamometer (37.6%), eccentric/resistance exercise (22.7%), downhill walking/running (14.9%), plyometric exercise (12.0%), prolonged aerobic exercise (>45 min; 4.3%), neuromuscular electrostimulation (1.4%) and others (e.g., team sports, intermittent exercise, eccentric cycling) (7.1%). These exercises were classified as monoarticular (47.5%) or polyarticular (52.5%). Monoarticular exercises were performed by knee extensors (80.6%), knee flexors (11.9%), plantar flexors (6.0%) and dorsiflexors (1.5%). Among the 3,089 participants, 2,001 participants were assessed for CK activity (64.8%), 1,974 for active DOMS (63.9%), 760 for passive DOMS (24.6%), 501 for Mb concentration (16.2%), 492 for ROM (15.9%), 486 for jump height (15.7%), 352 for the evoked torque response (11.4%), 247 for VAL (8.0%), 241 for PPT (7.8%), 185 for limb circumference (6.0%), 169 for LDH (5.5%), 154 for RTD (5.0%), 149 for IL-6 (4.8%), 52 for T2 in MRI (1.7%).

Measurement time points of each indirect marker in response to exercise are described in Figs 35. MVCloss 24-48h (SMD) values of each group are displayed in Fig 2 for the three clusters: low responders (LOW: SMD center = -0.29 ± 0.03, n = 50), moderate responders (MOD: SMD center = -0.81 ± 0.04, n = 52) and high responders (HIGH: SMD center = -1.81 ± 0.12, n = 39). Time-course changes in each indirect marker of the three clusters are described in Figs 4 and 5. SMD for each cluster was not calculated for PPT, limb circumference, VAL, RTD, LDH, IL-6 and T2, due to the lack of experimental groups in at least one cluster.

Fig 3. Time-course changes in pain pressure threshold (PPT), limb circumference, rate of torque development (RTD), voluntary activation level (VAL), lactate dehydrogenase (LDH), interleukin-6 (IL-6) and transverse relaxation time (T2) at < 6 h, 24h, 48h, 72h and > 96 h post-exercise.

Fig 3

The number in parenthesis represents the number of studies. Data are displayed as mean of standard mean difference (SMD) ± standard error. *: Significant difference from baseline at p < 0.05; *: **: Significant difference from baseline at p < 0.01; ***: Significant difference from baseline at p < 0.001.

Fig 5.

Fig 5

Time-course changes in active DOMS (a-b), passive DOMS (c-d), creatine kinase (e-f), and myoglobin (g-h). Standard mean difference (SMD) and standard error were displayed for all included groups (a, c, e, g) and for three clusters representing three levels of maximal voluntary contraction torque loss (b, d, f, h). The number in parenthesis represents the number of studies included in the analysis. Significant differences from baseline (before the damaging exercise) were displayed: *: p < 0.05; **: p < 0.01; ***; p < 0.001; ns: non-significant.

Fig 4.

Fig 4

Time-course changes in maximal voluntary contraction torque (a-b), evoked response (c-d), jump height (e-f), and range of motion (g-h) after exercise. Standard mean difference (SMD) and standard error were displayed for all included groups (a, c, e, g) and for three clusters representing three levels of maximal voluntary contraction torque loss (b, d, f, h). The number in parenthesis represents the number of studies. Significant differences from baseline (before the damaging exercise) were displayed: *: p < 0.05; **: p < 0.01; ***; p < 0.001; ns: non-significant.

Changes in EIMD markers: Time-course analysis

Markers of force-generating capacity

MVC torque. As expected, we found that time-course of MVC torque recovery was different between clusters (Fig 4B). MVC torque recovery was faster in the LOW and MOD clusters when compared with the HIGH cluster (Fig 4B). Indeed, a large effect of exercise on MVC torque (SMD = -1.18 ± 0.12) was still observed at 72 h in the HIGH cluster whereas small to moderate effects were found for the other clusters (LOW: SMD = -0.14 ± 0.05; MOD: SMD = -0.50 ± 0.06).

Jump height. Jump height showed greater decrease at 24–48 h post-exercise in the HIGH (SMD = -2.13 ± 0.72) than in the LOW (SMD = -0.47 ± 0.14) cluster after exercise (Fig 4F). Moreover, recovery was faster in LOW and MOD clusters when compared with the HIGH cluster. A large effect of exercise on jump height (SMD = -1.95 ± 0.28) was still observed at 72 h post-exercise in the HIGH cluster, whereas small effects were found for the other clusters (LOW: SMD = -0.44 ± 0.14; MOD: SMD = -0.21 ± 0.29).

Evoked torque response. A significant decrease in the amplitude of the evoked torque response was observed during the days following the exercises (Fig 4C). The decrease at 24–48 h post-exercise was larger for HIGH cluster (SMD = -1.21 ± 0.23) compared to the LOW (-0.33 ± 0.16) cluster (Fig 4D). The recovery took longer (> 96 h) in the HIGH cluster than MOD and LOW clusters (48 h) (Fig 4D). Indeed, a large effect of exercise on the amplitude of the evoked torque response was still observed at 48, 72 and 96 h post-exercise, whereas small to moderate and no effects were evident for the MOD and LOW clusters, respectively (Fig 4D).

Voluntary activation level. VAL was significantly decreased at <6 h (SMD = -0.71 ± 0.20) and 48 h (SMD = -0.36 ± 0.11) after the exercise (Fig 3). Time-course of this marker was not analyzed for each cluster due to lack of experimental groups in at least one cluster.

Rate of torque development. A moderate to large decrease of RTD was observed after the exercise (Fig 3). RTD reduction was the largest within 6 hours following exercise (SMD = -1.18 ± 0.24), transiently recovered at 24 h post-exercise (SMD = 0.53 ± 0.28; p = 0.06) and decreased again at 48 h post-exercise (SMD = -1.01 ± 0.26). Time-course of this marker was not analyzed for each cluster due to lack of experimental groups in at least one cluster.

Range of motion

A significant decrease in ROM was observed during the days following the exercises (Fig 4G). However, ROM was significantly reduced only in the MOD and HIGH clusters and the maximum decrease occurred at 48 h post-exercise for these clusters (SMD: -1.14 ± 0.48 and -1.29 ± 0.39, respectively) (Fig 4H). Moreover, ROM was reduced earlier after the end of the exercise in HIGH cluster (<6 h) compare to MOD cluster (48 h).

Delayed-onset muscle soreness

Increase in active and passive DOMS and decrease in PPT were observed and peaked 24 to 48 h after exercise (Fig 5A and 5C). DOMS peaked at 48 h post-exercise in the HIGH cluster but peaked at 24 h post-exercise in the LOW and MOD clusters. Moreover, the recovery was faster for the LOW compared to the MOD and HIGH clusters (Fig 5B and 5D). A large effect of exercise on active/passive DOMS was still observed at 72–96 h post-exercise in the HIGH cluster, whereas small to moderate effects were seen for the other clusters at these time points (Fig 5B and 5D).

Swelling

Limb circumference. A small decrease in limb circumference was observed only at 24 h post-exercise (SMD = 0.35 ± 0.15; Fig 3). Time-course of this marker was not analyzed for each cluster due to lack of experimental groups in at least one cluster.

Transverse relaxation time. T2 was significantly increased after exercise (Fig 3). Although no study assessed T2 at <6 h post-exercise, larger increases in T2 were observed at 48 to 96 h post-exercise (Fig 3). Time-course of this marker was not analyzed for each cluster due to lack of experimental groups in at least one cluster.

Blood markers

Creatine kinase (CK) activity. CK activity peaked, on average, 24 h post-exercise and remained elevated for up to 96 h post-exercise (Fig 5E). The time-course changes in CK activity differed as a function of clusters (Fig 5F). CK activity peaked 24 h after exercise for the LOW (SMD = 1.08 ± 0.14) and MOD (SMD = 0.92 ± 0.08) clusters and 72 h post-exercise for the HIGH cluster (SMD = 1.94 ± 0.27) (Fig 5F).

Myoglobin (Mb) concentration. Mb concentration peaked, on average, within 6 h and remained elevated for up to 96 h post-exercise (Fig 5G). The time-course of changes in Mb concentration also differed as a function of clusters (Fig 5H). The recovery of Mb concentration was longer in the MOD and HIGH clusters (< 96 h) when compared with the LOW cluster (24 h) (Fig 5H). The maximal Mb concentration was larger for the HIGH cluster (SMD = 2.58 ± 0.60) than the LOW (SMD = 0.66 ± 0.32) cluster.

Lactate dehydrogenase (LDH). LDH activity peaked 48 h post-exercise (SMD = 1.28 ± 0.24; Fig 3) remained elevated for up to 96 h post-exercise (SMD = 0.95 ± 0.31; Fig 3). Time-course of this marker was not analyzed for each cluster due to lack of experimental groups in at least one cluster.

Interleukin-6 (IL-6). Moderate increase in IL-6 concentration was observed <6 h after exercise (SMD = 0.51 ± 0.15; Fig 3). IL-6 was significantly increased only during the first 2 days following exercise (<6 h, 24 h and 48 h; Fig 3). Time-course of this marker was not analyzed for each cluster due to lack of experimental groups in at least one cluster.

Factors associated with the MVCloss 24-48h

The chi-square test of association showed a significant relationship between the level of MVCloss 24-48h (clusters) and the training status (p < 0.05), the exercise modality (p < 0.01) and the exercise type (p < 0.01) (Table 1). Trained participants were over-represented in the LOW cluster (44.0%) compared to the expected value (i.e., distribution in the whole sample) (27.7%) (Table 1A). Moreover, eccentric contractions using an isokinetic ergometer and monoarticular exercises were over-represented in the HIGH cluster compared to the expected value (56.4% vs. 37.6% and 64.1 vs. 47.5%, respectively) (Table 1B and 1C).

Meta-regression: Association between EIMD markers and MVCloss 24-48h

The results of the meta-regressions between MVCloss 24-48h and changes in other markers are shown in Table 2.

Associations within 6 h post-exercise

Changes in MVC torque within 6 h post-exercise was significantly correlated (r2 = 0.67; p < 0.001) with changes in MVCloss 24-48h. Jump height, ROM, active DOMS, limb circumference, VAL and Mb concentration changes observed within 6 hours after exercise (SMD value at <6 h) were also correlated with the largest changes in MVCloss 24-48h (Table 2).

Associations between 24 and 48 h post-exercise

Jump height, PPT, limb circumference, amplitude of the evoked torque response, RTD and T2 changes observed at 24 h post-exercise were correlated with the largest change in MVCloss 24-48h (Table 2). Similarly, ROM, active/passive DOMS, limb circumference, amplitude of the evoked torque response and T2 changes observed at 48 h post-exercise were correlated with the largest change in MVCloss 24-48h (Table 2).

Associations later than 48 h post-exercise

Jump height performance, active/passive DOMS, PPT, limb circumference, evoked torque response, VAL and CK activity changes observed at 72 h post-exercise were correlated with the largest change in MVCloss 24-48h (Table 2). Similarly, active DOMS, evoked torque response and RTD measured at >96 h post-exercise were correlated with MVCloss 24-48h (Table 2).

Discussion

This study was the first to quantitatively review the magnitude and time-course of the most common indirect markers of EIMD and cluster them based on levels of MVCloss 24-48h following lower limb eccentric-biased exercises. This approach was applied to an extensive dataset from 141 studies employing various exercise modalities and participant characteristics. Firstly, three different time-courses were identified, corresponding to three levels of MVCloss 24-48h (LOW, MOD, HIGH) for commonly used EIMD markers (e.g., CK activity, Mb concentration, DOMS, ROM). For instance, magnitude of changes is greater and recovery slower in HIGH cluster compare to other clusters for MVC torque, evoked torque response, jump height, Mb concentration and the peak may also be reached later in HIGH cluster compare to other clusters for DOMS and CK activity. Secondly, we showed that some factors such as training status and exercise type/modality partly explain the level of MVCloss 24-48h. For instance, eccentric contractions using an isokinetic dynamometer and monoarticular exercises induced larger MVCloss 24-48h than other exercises modalities and polyarticular exercises, respectively. Thirdly, some EIMD markers could serve as surrogate (e.g., jump height) to MVC or could be related to (e.g., Mb) the level of MVCloss 24-48h.

Changes in EIMD markers: Time-course analysis

Markers of force-generating capacity

The results of the present study showed that the larger the MVCloss 24-48h of the lower limb muscles, the longer the recovery (Fig 4B). This is consistent with Damas et al. [13] that reported time-course differences between three clusters computed from individual MVC torque loss after maximal eccentric exercise of the elbow flexors. The MVC torque recovery time-course is also consistent with a previous review by Paulsen et al. [11] who showed a longer recovery after “severe damage” compared to “mild” or “moderate” EIMD based on the MVC torque loss. Interestingly, we also found that the larger the MVCloss 24-48h (i.e., the larger EIMD), the longer the evoked torque response and jump height recovery. Unfortunately, we were unable to compare time-course of VAL and RTD at different levels of MVCloss 24-48h due to lack of studies assessing these markers in at least one cluster. However, we found that VAL was decreased during the first hours after the exercise (<6 h) and at 48 h post-exercise. RTD, a measure of ability of the neuromuscular system to rapidly produce torque during MVC, was decreased in the first hours following exercises (<6 h), but also 48 to 96 h post-exercise. As the ability of neural drive to activate muscle (i.e., VAL) was not affected 72 and 96 h after exercise in the present study, it could be speculated that the decreased RTD at these time points was likely due to peripheral factors. Consistently, it has been suggested [24, 25] that early phase RTD reflects neural mechanisms underlying exercise-induced torque loss, while late RTD may describe the same physiological mechanisms as MVC torque loss. The results of evoked torque response and VAL confirmed that MVC torque loss observed the hours/days after an EIMD event are due to peripheral (i.e., muscular) and central (i.e., nervous) alterations of the neuromuscular system. Moreover, we confirmed that recovery process to reestablish the force-generating capacity after a training session or an exercise intervention must be individually adapted as a function of extent of MVCloss 24-48h.

DOMS, ROM, and swelling

The present review confirmed that both passive and active DOMS peaked between 24 and 48 h after exercise, and showed that the greater the MVCloss 24-48h, the later the peak of DOMS occurs. Indeed, we found that DOMS peaked at 24 h after the exercise for LOW and MOD clusters, whereas it peaked at 48 h post-exercise for HIGH cluster. These results were not consistent with those reported by Damas et al. [13] who found that DOMS peaked 48 h after eccentric exercise of the elbow flexors, regardless of the level of MVC torque loss. Theses discrepancies could be due to the large type of exercise modalities, muscle groups and study designs included into the analysis in the present review, which differ from the specific model used by Damas et al. [13]. However, it is difficult to fully explain the delayed peak of DOMS after severe EIMD due to a complex etiology of pain [26]. For instance, muscle inflammation due to white cells infiltration (i.e., macrophages) [11] and intramuscular fluid pressure [27] due to muscle swelling could be different as function of the level of MVCloss 24-48h, inducing different time-courses of DOMS. Our results showed a small increase of limb circumference at 24 h post-exercise, whereas larger T2 MRI imagining elevation was observed 24 to 96 h post-exercise. As Damas et al. [13] reported that eccentric exercise of the elbow flexors induce an increase in limb circumference up to 120 h regardless of the level of MVCloss 24-48h, it could be speculated that this marker is more sensitive in upper limbs than lower limbs. Our results showed that ROM was not reduced the days after the exercises for the LOW cluster, while ROM decreased greatly at 48 h post-exercise for the MOD and HIGH clusters. Moreover, ROM was decreased within few hours (<6 h, 24 h) following exercise only in the HIGH cluster. In a clinical or sport context, reproducible, cheap, quickly and easy to use evaluations are important in order to provide a rapid and quantitative diagnosis of the impact of the exercise on the whole muscle system functionality. It could be suggested the assessment of limb circumference could be most appropriate and give more information about muscle swelling or EIMD when the damage is induced on the upper limbs muscles [9, 13]. Moreover, it seems that changes in muscle-tendon stiffness and the presence of edema represented by the measure of ROM [28] could be appear earlier (within the hours after exercise) and stay high longer (72 h) after severe EIMD.

Blood markers

Contrary to the above-mentioned indirect markers, circulating blood markers provide a whole body systemic information regarding EIMD. Indeed, when muscle fibers are damaged or permeability of sarcolemma is increased, intramuscular components are released into the extracellular space and bloodstream. Therefore, the increase in level of circulating markers has been often used to quantify EIMD [10, 29]. In the present study, an increase in CK and LDH activities and Mb concentrations were observed the days after the exercises, but with different time-courses, as already reported elsewhere [30, 31]. Because CK is cleared by the reticuloendothelial system and Mb is cleared through the liver and kidney [32], differences in time-course could be different among these blood markers. Moreover, Muslimovic et al. [32] reported a new mechanism of clearance through muscle cell endocytosis that could bring a new light to this phenomenon. While we found that peak of CK activity was not necessarily larger in HIGH cluster compared to LOW and MOD clusters the hours after the exercise, we found that CK activity peaked at 24 h post-exercise for the LOW and MOD clusters and at 72 h post-exercise for the HIGH cluster. Even though CK is largely used in the literature and in clinical practice, this marker does not seem to be sensitive to EIMD in the first hours after the damaging exercise. In line with Lippi et al. [31], the time-course of changes in Mb concentration after low EIMD (LOW cluster) showed a rapid increase and return to baseline within hours (<24 h) after the exercises. However, Mb levels could remain elevated for some days after exercise after moderate to severe EIMD (MOD and HIGH). The persistent elevation in Mb and CK the days after exercise in HIGH cluster could be at least partly explained by a secondary release of the myocyte content of CK and Mb the days after the end of the exercise. Indeed, it has been reported that secondary muscle damage and fiber necrosis could occur due to the loss of Ca2+ homeostasis and inflammatory process [11, 33]. The time-course of blood markers could inform on the muscle state during the days after the exercise since the peak of CK activity was delayed (from 24 h to 72 h) and Mb could remain elevated and after severe EIMD. It could be that the recovery of sarcolemma integrity is dependent of the level of EIMD. This has practical implications for the diagnosis of EIMD after exercise by focusing not only on the amplitude of the blood markers but also on their time-course.

Recommendations

Some discordance or asynchrony exists among EIMD markers. After severe EIMD (i.e., high level of MVCloss 24-48h), Mb concentration peaks at 6 h post-exercice, whereas ROM and DOMS peaked at 48h and CK at 72 h post-exercise, suggesting that the presence of high level of EIMD should be highlighted by different markers as function of the timing of measurement.

Factors affecting MVCloss 24-48h

Our results showed that the training level was a determinant of the magnitude of MVCloss 24-48h (Table 1). Indeed, this is consistent with Ertel et al. [34] who reported that untrained participants experienced greater EIMD symptoms than trained individuals. The present study also showed that eccentric contractions using an isokinetic ergometer resulted in larger MVCloss 24-48h when compared to other exercises. Similarly, we found that monoarticular exercises induced larger MVCloss 24-48h when compared to polyarticular exercises. This could be explained by the high proportion of monoarticular exercises performed at high intensity over a large range of motion using an isokinetic ergometer. Indeed, it has been shown that exercise intensity [35] and exercise range of motion [36, 37] are dominant factors affecting the magnitude of changes in EIMD markers (e.g. MVC torque loss). Unfortunately, it was impossible to compare the intensity of all the exercise models included in the present study due to the heterogeneity of the exercise types and the lack of information on the intensity of exercise in some studies. Our results regarding monoarticular and polyarticular exercises, were in line with Paulsen et al. [11] who stated that isolated eccentric muscle actions cause larger decreases in muscle function compared with eccentric-biased exercise (e.g., downhill running).

The methodological process of the present study revealed the lack of information regarding the participants and exercise model characteristics in many studies. Several participants’ characteristics such as age, sex, height, weight, training volume and type of exercise should be systematically and accurately reported. Similarly, several exercise parameters such as exercise intensity, duration and volume should be more clearly reported. If applicable, it is also important to report the mode and the velocity of muscle contraction, and the joint angle and the range of motion at which the contraction was performed. A better understanding of factors involved in the exercise could be helpful to better anticipate the magnitude of MVCloss 24-48h and better adapt recovery strategy and training loads of athletes. For instance, the more the subject is trained, the lower the EIMD and lesser the time to reestablish the muscle function between two mechanical stimuli.

EIMD markers reflecting MVCloss 24-48h

In order to evaluate whether EIMD markers could be used as indicators of muscle functional deficit, we compared the responses of these markers with the magnitude of MVCloss 24-48h by performing meta-regressions. Our results showed some significant associations between the responses of MVCloss 24-48h and other EIMD markers. These results suggest that some EIMD markers are suitable to partly predict (e.g., Mb) whereas other markers could be used as surrogate (e.g., jump height) to the measurement of MVCloss 24-48h.

Markers of force-generating capacity

A significant correlation was found between MVCloss 24-48h and evoked torque response changes at 24, 48, 72 and >96 h post-exercise (Table 2), suggesting that the amplitude of the evoked torque response could be used as a surrogate of the MVC torque without the necessity to perform maximal efforts. A significant correlation was also found between jump height loss at 24 h post-exercise and MVCloss 24-48h (r2 = 0.40), suggesting that jump height could be a practical, cheap and reliable alternative to evaluate the magnitude of MVCloss 24-48h. (i.e., the magnitude of EIMD). However, the early changes (<6 h) of both the evoked torque response and jump height were poorly associated with MVCloss 24-48h (Table 2). It is likely that early measurements of muscle function reflect the combined influence of metabolic fatigue and muscle damage [11], therefore explaining the poor correlation with the MVCloss 24-48h. Indeed, while we observed a better association of MVC torque loss at <6 h with MVCloss 24-48h than with early evoked response and jump height (<6 h), early MVC measurement does not seem to fully explain the observed MVCloss 24-48h (r2 = 0.67), likely due to metabolic/central fatigue. We found that the VAL decrease within 6 hours after exercises was associated with the MVCloss 24-48h, suggesting that the (in)-ability to voluntarily activate the motor units in the early phase after the exercise could partly predict the MVCloss 24-48h (i.e., indicate the magnitude of EIMD). However, early (<6 h) decrease in VAL is largely affected by muscle fatigue [38], limiting the use of this marker to predict the magnitude of MVCloss 24-48h. The presence of DOMS, swelling and inflammation at 48 h post-exercise in the present study could also be involved in the reduction of VAL observed 48 h after the exercise due to the sensitivity of group III-IV afferent fibers to nociceptive and mechanical (pressure) stimuli [38]. However, our results showed that the decrease in VAL at 48 h post-exercise was small, limiting its effect on the decrease in muscle function at this time-point. RTD, a measure of the ability of the neuromuscular system to rapidly produce torque during MVC, was decreased in the first hours following exercises (<6 h), but also 48 to 96 h post-exercise. Among these time-point, only a correlation between RTD at 96 h post-exercise and MVCloss 24-48h was found. Therefore, the present results were inconsistent with Penailillo et al. [25] who found that RTD at the 100–200 ms slot could be used as an early and sensitive marker of EIMD. These conflicting results could be explained by the different methods (early 0–50 vs late 100–200 ms windows) used to assess RTD. To sum up, jump height loss could be a practical, cheap and reliable alternative to evaluate the muscle function loss in EIMD context. Moreover, evoked torque response could be used as a surrogate of the MVC torque and allow to assess muscle function without the necessity to perform maximal efforts.

DOMS, ROM, and swelling

We found that DOMS (active/passive DOMS and PPT) was poorly associated with the MVCloss 24-48h (r2 < 0.28), suggesting that DOMS may be a poor indicator of EIMD. On the contrary, a moderate correlation was found between ROM changes at 48 h post-exercise and the magnitude of MVCloss 24-48h (r2 = 0.52), suggesting that ROM may be a better indicator of magnitude of EIMD at this time point. Despite the small elevation of limb circumference, associations were found between limb circumference changes at several time points post-exercise and the magnitude of MVCloss 24-48h (Table 2). This is consistent with Damas et al. [13] who found a correlation between MVC torque loss and arm circumference after eccentric exercise of the elbow flexors. Moreover, we found an association between T2 increase at 24–48 h post-exercise and MVCloss 24-48h. Thus, T2 seems to be suitable for evaluating the EIMD only after 24 h post-exercise. Our results should nevertheless be interpreted with caution due to the small number of studies assessing limb circumference and T2 MRI on the lower limbs.

Blood markers

Regarding systemic indirect markers of EIMD, only Mb concentration seems to early (<6 h post-exercise) estimate the magnitude of MVCloss 24-48h (Table 2). Although CK activity in blood is the most often used marker, it may not be suitable to accurately predict the magnitude of MVCloss 24-48h. Indeed, this marker partly reflects the magnitude of MVCloss 24-48h only 72 h post-exercise. Similarly, the lack of correlation between change in LDH activity and MVCloss 24-48h suggests that LDH measurement is not useful for the evaluation of the magnitude of EIMD, likely due to the non-specificity of LDH to myocytes [39]. Despite the small to moderate increase of IL-6 concentration the days after the exercises (Fig 3), this marker was not correlated to the magnitude of MVCloss 24-48h. This suggests that IL-6 concentration is not useful for the estimation of the magnitude of EIMD. These observations are consistent with those of Paulsen et al. [11] and Reihmane & Dela [40] who reported that discrepant changes in IL-6 concentrations among studies were explained by different exercise protocols and training status of the participants. Moreover, this large variability observed in the marker after eccentric exercise could be due to the various role of IL-6 in response to muscle contractions [41].

Recommendations

Among the most common used EIMD markers, Mb concentration or MVC torque loss should be used during the first hours after the exercise (<6 h), even if these markers only partly predict the MVCloss 24-48h due to high inter-individual variability and metabolic fatigue. MVC torque loss should be used beyond 24 h after the exercise, however, jump height loss and evoked torque response could be surrogates to this measure at these times points. It should be noted that ROM could be an easy and inexpensive alternative when the measure is performed 48 h after the exercise. Finally, the assessment of CK activity seems to be suitable only at 72 h post exercise to provide information on the muscle function.

Limitations

A few points may have influenced our results and deserve consideration. Firstly, the use of group values rather than individual values could limit the interpretation of the individual variability. Secondly, the assessment of EIMD markers was not always reported for all measurement time points, which limits the interpretation of the time-course changes in these markers, especially for the less frequently assessed markers. The fact that we reviewed only EIMD markers present in at least five studies and that we cannot characterize the time-course for each cluster for some markers, our analysis was limited to the most common used markers. Thirdly, majority of the studies included mainly males (81%), limiting the interpretation of the present results for females. Indeed, it has been shown that muscle function is less affected in female than male after an eccentrically-biased exercise [42]. The lower susceptibility of female to EIMD could be explained by several factors such as the smaller absolute MVC torque [43] or the role of sex hormones [44], but more studies should be performed in order to clarify this.

Conclusion

The present review was the first to examine the recovery time-course of the most frequently reported indirect markers of EIMD for different levels of MVCloss 24-48h. As some discordance or asynchrony exists among the most common used EIMD markers, different markers should be used as function of the timing of measurement. Mb concentration or MVC torque loss should be used during the first hours after the exercise (<6 h), even if these markers only partly predict the MVCloss 24-48h. Jump height loss and evoked torque response could be used as surrogate of the MVC torque loss. ROM could be an easy and inexpensive alternative when the measure is performed 48 h after the exercise, whereas the assessment of CK activity seems to be suitable only at 72 h post-exercise to provide information on the muscle function. Moreover, factors such as training status and exercise type/modality (e.g. monoarticular exercise, eccentric contractions using an isokinetic ergometer) could affect the magnitude of MVCloss 24-48h, and therefore affect the time to reestablish the muscle function between two mechanical stimuli.

Supporting information

S1 Data. Quality assessment.

(XLSM)

S1 Fig. Schematic flowchart of study selection from initial search to the final study inclusion.

(TIF)

Acknowledgments

We sincerely thank all support from all authors. No conflict of interest, financial or otherwise, is declared by the authors.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Ortega-Castillo M, Medina-Porqueres I. Effectiveness of the eccentric exercise therapy in physically active adults with symptomatic shoulder impingement or lateral epicondylar tendinopathy: A systematic review. Journal of science and medicine in sport. 2016;19(6):438–53. Epub 2015/08/26. doi: 10.1016/j.jsams.2015.06.007 . [DOI] [PubMed] [Google Scholar]
  • 2.Gremeaux V, Duclay J, Deley G, Philipp JL, Laroche D, Pousson M, et al. Does eccentric endurance training improve walking capacity in patients with coronary artery disease? A randomized controlled pilot study. Clin Rehabil. 2010;24(7):590–9. Epub 2010/06/10. doi: 10.1177/0269215510362322 . [DOI] [PubMed] [Google Scholar]
  • 3.Hernandez HJ, McIntosh V, Leland A, Harris-Love MO. Progressive Resistance Exercise with Eccentric Loading for the Management of Knee Osteoarthritis. Frontiers in medicine. 2015;2:45. Epub 2015/07/29. doi: 10.3389/fmed.2015.00045 ; PubMed Central PMCID: PMC4497310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Inostroza M, Valdés O, Tapia G, Núñez O, Kompen MJ, Nosaka K, et al. Effects of eccentric vs concentric cycling training on patients with moderate COPD. European journal of applied physiology. 2022;122(2):489–502. Epub 2021/11/21. doi: 10.1007/s00421-021-04850-x . [DOI] [PubMed] [Google Scholar]
  • 5.Harris-Love MO, Gollie JM, Keogh JWL. Eccentric Exercise: Adaptations and Applications for Health and Performance. J Funct Morphol Kinesiol. 2021;6(4). Epub 2021/11/30. doi: 10.3390/jfmk6040096 ; PubMed Central PMCID: PMC8628948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Roig M, O’Brien K, Kirk G, Murray R, McKinnon P, Shadgan B, et al. The effects of eccentric versus concentric resistance training on muscle strength and mass in healthy adults: a systematic review with meta-analysis. British journal of sports medicine. 2009;43(8):556–68. Epub 2008/11/05. doi: 10.1136/bjsm.2008.051417 . [DOI] [PubMed] [Google Scholar]
  • 7.McNeill C, Beaven CM, McMaster DT, Gill N. Eccentric Training Interventions and Team Sport Athletes. J Funct Morphol Kinesiol. 2019;4(4). Epub 2019/09/27. doi: 10.3390/jfmk4040067 ; PubMed Central PMCID: PMC7739426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.LaStayo P, Marcus R, Dibble L, Frajacomo F, Lindstedt S. Eccentric exercise in rehabilitation: safety, feasibility, and application. Journal of applied physiology (Bethesda, Md: 1985). 2014;116(11):1426–34. Epub 2013/07/05. doi: 10.1152/japplphysiol.00008.2013 . [DOI] [PubMed] [Google Scholar]
  • 9.Clarkson PM, Hubal MJ. Exercise-induced muscle damage in humans. American journal of physical medicine & rehabilitation. 2002;81(11 Suppl):S52–69. doi: 10.1097/01.PHM.0000029772.45258.43 . [DOI] [PubMed] [Google Scholar]
  • 10.Warren GL, Lowe DA, Armstrong RB. Measurement tools used in the study of eccentric contraction-induced injury. Sports medicine. 1999;27(1):43–59. Epub 1999/02/24. doi: 10.2165/00007256-199927010-00004 . [DOI] [PubMed] [Google Scholar]
  • 11.Paulsen G, Mikkelsen UR, Raastad T, Peake JM. Leucocytes, cytokines and satellite cells: what role do they play in muscle damage and regeneration following eccentric exercise? Exercise immunology review. 2012;18:42–97. Epub 2012/08/11. . [PubMed] [Google Scholar]
  • 12.Abernethy P, Wilson G, Logan P. Strength and power assessment. Issues, controversies and challenges. Sports medicine. 1995;19(6):401–17. Epub 1995/06/01. doi: 10.2165/00007256-199519060-00004 . [DOI] [PubMed] [Google Scholar]
  • 13.Damas F, Nosaka K, Libardi CA, Chen TC, Ugrinowitsch C. Susceptibility to Exercise-Induced Muscle Damage: a Cluster Analysis with a Large Sample. International journal of sports medicine. 2016;37(8):633–40. Epub 2016/04/27. doi: 10.1055/s-0042-100281 . [DOI] [PubMed] [Google Scholar]
  • 14.Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. Epub 2015/01/03. doi: 10.1186/2046-4053-4-1 ; PubMed Central PMCID: PMC4320440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Wallace BC, Small K, Brodley CE, Lau J, Trikalinos TA. Deploying an interactive machine learning system in an evidence-based practice center: abstrackr. Proceedings of the 2nd ACM SIGHIT International Health Informatics Symposium; Miami, Florida, USA: Association for Computing Machinery; 2012. p. 819–24. [Google Scholar]
  • 16.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Esp Cardiol (Engl Ed). 2021;74(9):790–9. Epub 2021/08/28. doi: 10.1016/j.rec.2021.07.010 . [DOI] [PubMed] [Google Scholar]
  • 17.Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671–5. Epub 2012/08/30. doi: 10.1038/nmeth.2089 ; PubMed Central PMCID: PMC5554542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377–84. Epub 1998/10/09. doi: 10.1136/jech.52.6.377 PubMed Central PMCID: PMC1756728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hedges LV. Distribution Theory for Glass’s Estimator of Effect size and Related Estimators. Journal of Educational and Behavioral Statistics. 1981;6(2):107–28. [Google Scholar]
  • 20.Faraone SV. Interpreting estimates of treatment effects: implications for managed care. P T. 2008;33(12):700–11. . [PMC free article] [PubMed] [Google Scholar]
  • 21.Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, N.J.: L. Erlbaum Associates; 1988. [Google Scholar]
  • 22.Borenstein M, Hedges L, Higgins J, Rothstein H. An Introduction to Meta-Analysis. Introduction to Meta-Analysis. 2009;19. doi: 10.1002/9780470743386 [DOI] [Google Scholar]
  • 23.Maechler M, Rousseeuw P, Struyf A, Hubert M, Hornik K. Cluster: cluster analysis basics and extensions. R package version. 2012;1(2):56. [Google Scholar]
  • 24.Jenkins Housh TJ, Traylor DA Cochrane KC, Bergstrom HC Lewis RW, et al. The rate of torque development: a unique, non-invasive indicator of eccentric-induced muscle damage? International journal of sports medicine. 2014;35(14):1190–5. Epub 2014/09/27. doi: 10.1055/s-0034-1375696 . [DOI] [PubMed] [Google Scholar]
  • 25.Penailillo L, Blazevich A, Numazawa H, Nosaka K. Rate of force development as a measure of muscle damage. Scandinavian journal of medicine & science in sports. 2015;25(3):417–27. doi: 10.1111/sms.12241 . [DOI] [PubMed] [Google Scholar]
  • 26.Lewis PB, Ruby D, Bush-Joseph CA. Muscle soreness and delayed-onset muscle soreness. Clin Sports Med. 2012;31(2):255–62. Epub 2012/02/22. doi: 10.1016/j.csm.2011.09.009 . [DOI] [PubMed] [Google Scholar]
  • 27.Crenshaw AG, Thornell LE, Fridén J. Intramuscular pressure, torque and swelling for the exercise-induced sore vastus lateralis muscle. Acta physiologica Scandinavica. 1994;152(3):265–77. Epub 1994/11/01. doi: 10.1111/j.1748-1716.1994.tb09806.x . [DOI] [PubMed] [Google Scholar]
  • 28.Howell JN, Chleboun G, Conatser R. Muscle stiffness, strength loss, swelling and soreness following exercise-induced injury in humans. The Journal of physiology. 1993;464:183–96. Epub 1993/05/01. doi: 10.1113/jphysiol.1993.sp019629 ; PubMed Central PMCID: PMC1175380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Brancaccio P, Lippi G, Maffulli N. Biochemical markers of muscular damage. Clinical chemistry and laboratory medicine. 2010;48(6):757–67. Epub 2010/06/04. doi: 10.1515/cclm.2010.179 . [DOI] [PubMed] [Google Scholar]
  • 30.Peake JM, Suzuki K, Wilson G, Hordern M, Nosaka K, Mackinnon L, et al. Exercise-induced muscle damage, plasma cytokines, and markers of neutrophil activation. Medicine and science in sports and exercise. 2005;37(5):737–45. Epub 2005/05/05. doi: 10.1249/01.mss.0000161804.05399.3b . [DOI] [PubMed] [Google Scholar]
  • 31.Lippi G, Schena F, Ceriotti F. Diagnostic biomarkers of muscle injury and exertional rhabdomyolysis. Clinical chemistry and laboratory medicine. 2018;57(2):175–82. Epub 2018/09/03. doi: 10.1515/cclm-2018-0656 . [DOI] [PubMed] [Google Scholar]
  • 32.Muslimovic A, Fridén V, Starnberg K, Tenstad O, Espedal H, Vukusic K, et al. Novel clearance of muscle proteins by muscle cells. Eur J Cell Biol. 2020;99(8):151127. Epub 2020/11/10. doi: 10.1016/j.ejcb.2020.151127 . [DOI] [PubMed] [Google Scholar]
  • 33.Lapointe BM, Frenette J, Côté CH. Lengthening contraction-induced inflammation is linked to secondary damage but devoid of neutrophil invasion. Journal of applied physiology (Bethesda, Md: 1985). 2002;92(5):1995–2004. Epub 2002/04/19. doi: 10.1152/japplphysiol.00803.2001 . [DOI] [PubMed] [Google Scholar]
  • 34.Ertel KA, Hallam JE, Hillman AR. The effects of training status and exercise intensity on exercise-induced muscle damage. The Journal of sports medicine and physical fitness. 2020;60(3):449–55. Epub 2020/01/21. doi: 10.23736/s0022-4707.19.10151-x . [DOI] [PubMed] [Google Scholar]
  • 35.Nosaka K, Newton M. Difference in the magnitude of muscle damage between maximal and submaximal eccentric loading. Journal of strength and conditioning research. 2002;16(2):202–8. Epub 2002/05/07. . [PubMed] [Google Scholar]
  • 36.Fochi AG, Damas F, Berton R, Alvarez I, Miquelini M, Salvini TF, et al. Greater eccentric exercise-induced muscle damage by large versus small range of motion with the same end-point. Biology of sport. 2016;33(3):285–9. Epub 2016/09/08. doi: 10.5604/20831862.1208480 ; PubMed Central PMCID: PMC4993145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Sadacharan CM, Seo S. Effect of Large Versus Small Range of Motion in the Various Intensities of Eccentric Exercise-Induced Muscle Pain and Strength. International journal of exercise science. 2021;14(7):1–18. Epub 2021/06/01. ; PubMed Central PMCID: PMC8136596. [PMC free article] [PubMed] [Google Scholar]
  • 38.Gandevia SC. Spinal and supraspinal factors in human muscle fatigue. Physiological reviews. 2001;81(4):1725–89. Epub 2001/10/03. doi: 10.1152/physrev.2001.81.4.1725 . [DOI] [PubMed] [Google Scholar]
  • 39.Sorichter S, Puschendorf B, Mair J. Skeletal muscle injury induced by eccentric muscle action: muscle proteins as markers of muscle fiber injury. Exercise immunology review. 1999;5:5–21. Epub 1999/10/16. . [PubMed] [Google Scholar]
  • 40.Reihmane D, Dela F. Interleukin-6: possible biological roles during exercise. European journal of sport science. 2014;14(3):242–50. Epub 2014/03/25. doi: 10.1080/17461391.2013.776640 . [DOI] [PubMed] [Google Scholar]
  • 41.Fischer CP. Interleukin-6 in acute exercise and training: what is the biological relevance? Exercise immunology review. 2006;12:6–33. Epub 2007/01/05. . [PubMed] [Google Scholar]
  • 42.Temesi J, Arnal PJ, Rupp T, Feasson L, Cartier R, Gergele L, et al. Are Females More Resistant to Extreme Neuromuscular Fatigue? Medicine and science in sports and exercise. 2015;47(7):1372–82. Epub 2014/10/12. doi: 10.1249/mss.0000000000000540 . [DOI] [PubMed] [Google Scholar]
  • 43.Hunter SK, Enoka RM. Sex differences in the fatigability of arm muscles depends on absolute force during isometric contractions. Journal of applied physiology (Bethesda, Md: 1985). 2001;91(6):2686–94. Epub 2001/11/22. doi: 10.1152/jappl.2001.91.6.2686 . [DOI] [PubMed] [Google Scholar]
  • 44.Komulainen J, Koskinen SO, Kalliokoski R, Takala TE, Vihko V. Gender differences in skeletal muscle fibre damage after eccentrically biased downhill running in rats. Acta physiologica Scandinavica. 1999;165(1):57–63. Epub 1999/03/11. doi: 10.1046/j.1365-201x.1999.00481.x . [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Xin Ye

26 Apr 2022

PONE-D-22-07742Appropriateness of indirect markers of muscle damage following lower limbs eccentric-biased exercises: A systematic review with meta-analysisPLOS ONE

Dear Dr. Chalchat,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Both reviewers and myself read your paper carefully, and I fully agree with the comments that the reviewers have provided. Overall, the systematic review was well-written. There are, however, some areas can be improved (see the detailed comments from the reviewers). In addition to addressing the detailed comments and make relevant revisions, I'd like to invite the authors to double check the updated 2020 PRISMA guidelines, and to make sure this review follows the new guidelines.

Please submit your revised manuscript by Jun 10 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Xin Ye, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: General Comments:

I’d like to commend the authors on a well-written manuscript. However, I would like to point out that the PRISMA guidelines used for the manuscript are the 2015 guidelines, which were updated in 2020 (PRISMA (prisma-statement.org). The authors will need to check the reporting to ensure they are in compliance with PRISMA guidelines and update the manuscript accordingly. Additionally, the data availability statement indicates that all data are freely accessible within the manuscript and supporting information files, but there is not a data file provided within the supporting materials. This is also something that is a component of the PRISMA 2020 guidelines (item 27), so the authors should provide files of the raw data used for analysis in supplementary files and/or a public repository. Specific comments below.

Abstract:

I accept the abstract as is.

Introduction:

Page 3, line 54: The sentence beginning with “Despite….” Is confusing. I recommend changing “unaccustomed, strenuous exercise and specially involving lengthening contractions, or with a repetition of stretch-shortening cycles” to something like “lengthening contractions can alter the ultrastructure of the muscle tissue…” to improve clarity.

Methods:

Page 4, line 95: Was this protocol registered prior to data analysis? Per PRISMA guidelines (item 24a-b), please state where the protocol registration can be found (e.g. link to repository) or state that the protocol was not registered.

Page 4, line 95: Were amendments made to the protocol over the course of data aggregation and performance of analysis? Per PRISMA guidelines (item 24c), details of the protocol development process should be provided.

Page 5, line 108: Please explain what is meant by “an accurate device”. Was there a list of devices that were included/excluded? If so, please include what those criteria were.

Page 5, line 113: As I said above, these guidelines are outdated, and the manuscript currently hasn’t addressed all aspects of the updated guidelines. Please revisit this after updating the manuscript according to updated guidelines and citation.

Page 7, line 161: Are the R scripts used to conduct analyses publicly available? Per PRISMA guidelines (item 27), if they are available this should be indicated.

Page 7, lines 174 – 183: Were all analyses (k-medioids clustering, Chi-square test, meta-regressions) performed in R? If so, please clarify this.

Results:

Page 8, line 185: Was the risk of bias assessed for all included studies for outcomes of interest? Please indicate this within the results.

Page 11, line 274: What is meant by certain categories being “over-represented”, e.g. “ trained participants were over-represented in the LOW cluster”. How is this being assessed?

Discussion:

Page 12, line 306: To clarify, what is meant by polyarticular exercises? Are you referring to exercises involving multiarticular muscles (e.g. hamstrings) or exercises including movement at multiple joints? This point is important because if you’re referring to multiarticular muscles, it would seem to contradict previous findings of increased damage in those types of muscles such as the hamstrings. Please clarify.

Page 12, line 307: I’m not sure that the point around using measures as surrogate markers is particularly strong, especially related to evoked torque responses. Any scenario involving evoked torque responses would also by definition have to include the ability to measure torque, at which point partial estimation of torque loss will provide less value than direct assessment. Additionally, it doesn’t seem like the results from the study provide support for estimating MVIC loss based on variables such as myoglobin. While the changes were related, relationships don’t necessarily imply a predictive capacity.

Reviewer #2: Summary:

This meta-analysis describes a beautiful synthesis of the data from 141 studies and analyzed the time-courses of the most common used indirect markers of exercise-induced muscle damage (EIMD) based on the different levels of maximal voluntary contraction torque loss at 24-48h post-exercise (MVCloss24-48h). It also assessed the correlations between MVCloss24-48h and the EIMD markers as well as the association between MVCloss24-48h and factors such as subjects’ training status and exercise modalities. The major findings include the different time-courses of the EIMD markers corresponding to different levels of MVCloss24-48h, different correlations between the EIMD markers and MVCloss24-48h at different time points, and the significant relationship between MVCloss24-48h and the training status and exercise modalities. The authors concluded that different EIMD markers should be used as function of the measurement time. For example, blood myoglobin concentration should be used during the first 6 hours following the exercise whereas ROM and CK should be measured at 48h and 72h post-exercise, respectively. In addition, training status and exercise modalities can affect the magnitude of MVCloss24-48h and thus influence the time courses of the EIMD markers.

Overall, this is a well-conducted meta-analysis which provides valuable guidance in the design of future studies involving EIMD assessment.

Only some clarifications and minor revisions are needed:

1. Redundant data description in Figure 3 and Figure 4&5.

- The time-courses of MVC, Evoked response, Jump height, ROM (Figure 4a,c,e,g), Active DOMS, passive DOMS, Ck, Mb (Figure 5a,c,e,g) are also described in Figure 3. This reviewer found the data displays in Figure 4&5 are better and easier to understand. So, this reviewer would recommend deleting the redundantly displayed data in Figure 3 and combine the leftover parts with those of Figure 4&5.

2. Why only the lower-limb exercise studies were included?

3. Line 132: “ volume (sedentary, active, trained),”

- What are the definitions of being sedentary, active and trained, especially the difference between “active” and “trained” subjects?

4. Terminology inconsistency.

Line 134: “type of exercise (monoarticular, polyarticular)”

- This is inconsistent with Figure 2, in which Exercise Type column seemly means the exercise modality in the texts of line 134. I assume the column title in the figure 2 should be Exercise Modality instead of Exercise Type.

5. Lines 154-155: “Cohen’s criteria were used to interpret the magnitude of the absolute SMD: <|0.50|:small;|0.50| to |0.80|:moderate; and >|0.80|: large”

- In Figure 2, the SMD values in the three clusters (LOW, MODERATE, HIGH) don’t match with the above definition in the above texts. For instance, some SMD values in the LOW cluster were higher than 0.5, same question for the MODERATE cluster.

6. Lines 177-178: “Meta-regressions were performed to investigate the association between the changes in MVCloss24-48h and changes in indirect markers at each time-point”

- The MVCloss24-48h changes of each individual or each study?

7. Lines 208-209: “MVC torque recovery was faster in the LOW and MOD clusters when compared with the HIGH cluster (Figure 4b).”

- In the method or Figure 4b, it was not mentioned what kind the statistical analysis was used to compare between the clusters. In Figure 4b, the significant difference between the time points and the pre-exercise level was shown. Same issue with all the other markers’ data in Figure 4&5.

8. Lines 305-306: “eccentric contractions using an isokinetic dynamometer and monoarticular exercises induced larger MVCloss 24-48h than other exercises modalities and polyarticular exercises”

- Same issue as in item#7. What are the statistical analysis data that the statement was based on?

9. Lines 441-442: “We found that DOMS (active/passive DOMS and PPT) was poorly associated with the MVCloss 24-48h, suggesting that DOMS should not be used to evaluate the magnitude of EIMD.”

- Is this statement correct? In Table 2, active DOMS was significantly associated with MVCloss 24-48h at <6h, 48h, 72h, and >96h post-exercise, which is similar as that of ROM. So, this review is confused about the statement.

10. Typo in Table 2. In the first column in Table 2, RFD should be changed into “RTD”.

11. The “n” in Table 2, Figure 2 &3 needs to be defined. Does the “n” represent the number of subjects or number of studies?

12. What are the numbers in the parenthesis in Figure 4&5? Does each of them represent the number of the studies?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Jul 14;17(7):e0271233. doi: 10.1371/journal.pone.0271233.r002

Author response to Decision Letter 0


25 May 2022

R1: PONE-D-22-07742 “Appropriateness of indirect markers of muscle damage following lower limbs eccentric-biased exercises: A systematic review with meta-analysis”

Dear editor/reviewers,

The authors would like to thank the editor and reviewers for their constructive and fair comments. The reviewers’ comments and suggestions are shown below (in Italic). Point-by-point answers to the reviewer’s comments are also provided below. We have copied and pasted the modified sentences from the revised manuscript in this point-by-point responses, and indicated the corresponding page and line numbers of the revised manuscript.

We hope that you will find that your comments and suggestions have been adequately considered and reflected in the revised manuscript. We appreciate your help to review the manuscript again.

Editor

Both reviewers and myself read your paper carefully, and I fully agree with the comments that the reviewers have provided. Overall, the systematic review was well-written. There are, however, some areas can be improved (see the detailed comments from the reviewers). In addition to addressing the detailed comments and make relevant revisions, I'd like to invite the authors to double check the updated 2020 PRISMA guidelines, and to make sure this review follows the new guidelines.

Reviewer #1

General Comments:

I’d like to commend the authors on a well-written manuscript. However, I would like to point out that the PRISMA guidelines used for the manuscript are the 2015 guidelines, which were updated in 2020 (PRISMA (prisma-statement.org). The authors will need to check the reporting to ensure they are in compliance with PRISMA guidelines and update the manuscript accordingly. Additionally, the data availability statement indicates that all data are freely accessible within the manuscript and supporting information files, but there is not a data file provided within the supporting materials. This is also something that is a component of the PRISMA 2020 guidelines (item 27), so the authors should provide files of the raw data used for analysis in supplementary files and/or a public repository. Specific comments below.

As suggested by the reviewer, we updated the PRISMA checklist according to the 2020 version and we provided raw data as supplemental data (page 5, L.129; page 8, L.195).

Abstract:

I accept the abstract as is.

We appreciate this comment. No further change has been made.

Introduction:

Page 3, line 54: The sentence beginning with “Despite….” Is confusing. I recommend changing “unaccustomed, strenuous exercise and specially involving lengthening contractions, or with a repetition of stretch-shortening cycles” to something like “lengthening contractions can alter the ultrastructure of the muscle tissue…” to improve clarity.

As suggested by the reviewer, we modified this sentence according to his/her suggestion. Now, it read (page 3, L.54-56): “Despite the benefits of this type of exercise, lengthening contractions can alter the ultrastructure of the muscle tissue and induce exercise-induced muscle damage (EIMD) [9]”

Methods:

Page 4, line 95: Was this protocol registered prior to data analysis? Per PRISMA guidelines (item 24a-b), please state where the protocol registration can be found (e.g. link to repository) or state that the protocol was not registered.

The protocol for this systematic review was not registered prior to data analysis. As it is not possible to perform this registration retrospectively on PROSPERO, we cannot provide a registration number. Therefore, we have specified in the manuscript that this protocol was not registered prior to data analysis (page 4, L.101): “The review was not registered and all necessary information is provided in the present manuscript.”, as suggested by the PRISMA guidelines.

Page 4, line 95: Were amendments made to the protocol over the course of data aggregation and performance of analysis? Per PRISMA guidelines (item 24c), details of the protocol development process should be provided.

We did not register the data analysis, however, no amendments were performed during the analysis process. Thus, the lack of registration should not reduce the quality of the work.

Page 5, line 108: Please explain what is meant by “an accurate device”. Was there a list of devices that were included/excluded? If so, please include what those criteria were.

We agree with the reviewer that this statement was ambiguous. Therefore, we amended the sentence as follows (page 5, L.109): “the outcome measures included isometric and dynamic articular joint torque using an isokinetic dynamometer or a load cell »

Page 5, line 113: As I said above, these guidelines are outdated, and the manuscript currently hasn’t addressed all aspects of the updated guidelines. Please revisit this after updating the manuscript according to updated guidelines and citation.

We updated the reference 16 according to the 2020 guidelines (page 5, L.115), and we have checked the “PRISMA 2020 checklist”, which has been provided in this submission.

Page 7, line 161: Are the R scripts used to conduct analyses publicly available? Per PRISMA guidelines (item 27), if they are available this should be indicated.

The scripts are publicly available. This is now specified on page 7, L.169: “The script used to perform the analysis is available at: https://github.com/SirJul/Chalchat-2022---Meta-analysis.”

Page 7, lines 174 – 183: Were all analyses (k-medioids clustering, Chi-square test, meta-regressions) performed in R? If so, please clarify this.

Jamovi and Comprehensive Meta-analysis software were used for analyses. This is now clarified in the revised version of the manuscript: “A Chi-square test of association was performed using Jamovi (The jamovi project (2020). jamovi (Version 1.2) [Computer Software]. Retrieved from https://www.jamovi.org, Sydney, Australia)” (page 7, L.180-181) and “Meta-regressions were performed using Comprehensive Meta-analysis software” (page 8, L.185).

Results:

Page 8, line 185: Was the risk of bias assessed for all included studies for outcomes of interest? Please indicate this within the results.

The risk of bias was assessed by “an adapted checklist proposed by Downs & Black (1998)”. (page 5, L.129) (Figure 2; supplemental data 1). As suggested by the reviewer, this is now indicated in the results section (page 8, L.195): “The results of the quality assessment of the included studies is provided in Figure 2 and supplemental data 1.”

Page 11, line 274: What is meant by certain categories being “over-represented”, e.g. “trained participants were over-represented in the LOW cluster”. How is this being assessed?

One of the aims of this study was to investigate the relationship between the level of MVCloss 24-48h (clusters) and the characteristics of participants (age, sex, training status) and exercise type/modality. The result (page 11, L.278-283) mentioned by the reviewer means that there are more trained participants on the LOW cluster compared to the overall sample. This was assessed by using a Chi-square test of association, comparing the distribution of trained participants in the LOW cluster to the expected values (i.e., the distribution in the whole sample). Minor modifications were added to this paragraph to clarify the results. This section now reads (page 11, L.280-283): “Trained participants were over-represented in the LOW cluster (44.0 %) compared to the expected value (i.e., distribution in the whole sample) (27.7 %) (Table 1a). Moreover, eccentric contractions using an isokinetic ergometer and monoarticular exercises were over-represented in the HIGH cluster compared to the expected value (56.4 % vs. 37.6 % and 64.1 vs. 47.5 %, respectively) (Table 1b and 1c).”

Discussion:

Page 12, line 306: To clarify, what is meant by polyarticular exercises? Are you referring to exercises involving multiarticular muscles (e.g. hamstrings) or exercises including movement at multiple joints? This point is important because if you’re referring to multiarticular muscles, it would seem to contradict previous findings of increased damage in those types of muscles such as the hamstrings. Please clarify.

We agree that this information is important and was lacking in the previous version of the manuscript. In this work, “Polyarticular exercises refer to exercises involving movement at multiple joints”. This has been added (page 5, L.134-135) in the methods section.

Page 12, line 307: I’m not sure that the point around using measures as surrogate markers is particularly strong, especially related to evoked torque responses. Any scenario involving evoked torque responses would also by definition have to include the ability to measure torque, at which point partial estimation of torque loss will provide less value than direct assessment. Additionally, it doesn’t seem like the results from the study provide support for estimating MVIC loss based on variables such as myoglobin. While the changes were related, relationships don’t necessarily imply a predictive capacity.

We agree that assessment of MVC torque is easier to perform than the assessment of evoked torque responses, therefore, MVC torque assessment should be performed rather than evoked torque responses assessment. However, as stated page 16, L.422-423: “the evoked torque response could be used as a surrogate of the MVC torque without the necessity to perform maximal efforts”. We removed “evoked torque response” page 12, L.313-314, as this result was not the most relevant. The sentence now reads: “Thirdly, some EIMD markers could serve as surrogate (e.g., jump height) to MVC “.

We also agree that the relationships do not necessarily imply a predictive capacity, therefore, we tempered our interpretation. The text was amended as follows: “Thirdly, some EIMD markers could serve as surrogate (e.g., jump height) to MVC or could be related to (e.g., Mb) the level of MVCloss 24-48h” (page 12, L.313-315).

Reviewer #2

Summary:

This meta-analysis describes a beautiful synthesis of the data from 141 studies and analyzed the time-courses of the most common used indirect markers of exercise-induced muscle damage (EIMD) based on the different levels of maximal voluntary contraction torque loss at 24-48h post-exercise (MVCloss24-48h). It also assessed the correlations between MVCloss24-48h and the EIMD markers as well as the association between MVCloss24-48h and factors such as subjects’ training status and exercise modalities. The major findings include the different time-courses of the EIMD markers corresponding to different levels of MVCloss24-48h, different correlations between the EIMD markers and MVCloss24-48h at different time points, and the significant relationship between MVCloss24-48h and the training status and exercise modalities. The authors concluded that different EIMD markers should be used as function of the measurement time. For example, blood myoglobin concentration should be used during the first 6 hours following the exercise whereas ROM and CK should be measured at 48h and 72h post-exercise, respectively. In addition, training status and exercise modalities can affect the magnitude of MVCloss24-48h and thus influence the time courses of the EIMD markers.

Overall, this is a well-conducted meta-analysis which provides valuable guidance in the design of future studies involving EIMD assessment.

We appreciate this reviewer´s kind words. This review and meta-analysis was performed to quantitatively summarize the information available regarding markers of muscle damage in the lower limbs

Only some clarifications and minor revisions are needed:

1. Redundant data description in Figure 3 and Figure 4&5.

- The time-courses of MVC, Evoked response, Jump height, ROM (Figure 4a,c,e,g), Active DOMS, passive DOMS, Ck, Mb (Figure 5a,c,e,g) are also described in Figure 3. This reviewer found the data displays in Figure 4&5 are better and easier to understand. So, this reviewer would recommend deleting the redundantly displayed data in Figure 3 and combine the leftover parts with those of Figure 4&5.

As suggested by the reviewer, we removed the redundant data from the figure 3 and we displayed figures similarly to figures 4 and 5. Please see Figure 3, 4 and 5.

2. Why only the lower-limb exercise studies were included?

We chose to focus on lower limb exercises rather than upper-limb exercises due to their involvement and importance on locomotion and daily activities. Moreover, the response of some EIMD markers on upper limbs eccentric exercise was already reported (Damas et al., 2016) in an original study including 286 participants. This meta-analysis was designed to extend this approach to the lower-limb muscles, as no study has previously summarize the responses to eccentric exercise on these muscles.

3. Line 132: “ volume (sedentary, active, trained),”

- What are the definitions of being sedentary, active and trained, especially the difference between “active” and “trained” subjects?

We thank the reviewer for this comment since this information was missing and was important to understand how the responses to eccentric exercise was influenced by the training status. We clarified this point (page 6, L.135-137): “Training volume was coded as follow: sedentary (no exercise), active (> 0 h/week and < 3 h/week), and trained (> 3 h/week) based on information available on the articles.”

4. Terminology inconsistency.

Line 134: “type of exercise (monoarticular, polyarticular)”

- This is inconsistent with Figure 2, in which Exercise Type column seemly means the exercise modality in the texts of line 134. I assume the column title in the figure 2 should be Exercise Modality instead of Exercise Type.

This reviewer is correct. We have modified figure 2. Now, it reads “exercise modality”.

5. Lines 154-155: “Cohen’s criteria were used to interpret the magnitude of the absolute SMD: <|0.50|:small;|0.50| to |0.80|:moderate; and >|0.80|: large”

- In Figure 2, the SMD values in the three clusters (LOW, MODERATE, HIGH) don’t match with the above definition in the above texts. For instance, some SMD values in the LOW cluster were higher than 0.5, same question for the MODERATE cluster.

The aim of the study was to characterize the magnitude and time-course of commonly used indirect markers of EIMD over different levels of muscle function loss at 24-48 h post-exercise. The levels of muscle function loss were not build based on the Cohen’s criteria, but based on a k-medoids clustering (page 7, L.166): “A k-medoids clustering (Partitioning around medoids) was done using R (R Core Team; 2020. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org) and the optimal number of clusters was determined using the NbClust R [23]. The script used to perform the analysis is available at: https://github.com/SirJul/Chalchat-2022---Meta-analysis. This clustering analysis was used to classify 141 experimental groups into 3 categories (clusters) based on the largest reduction in SMD torque at 24-48 h post-exercise (MVCloss 24-48h) of each group. Thus, experimental groups were classified as low responders (cluster 1; LOW), moderate responders (cluster 2; MOD) and high responders (cluster 3; HIGH) according to the magnitude of MVCloss 24-48h (i.e., SMD). This approach allowed us to divide a set of data into different homogeneous "groups", which is important to sum up the data. As the colors used in figure 3 in the previous version of the manuscript could be ambiguous, we modified. Please see Figure 3.

6. Lines 177-178: “Meta-regressions were performed to investigate the association between the changes in MVCloss24-48h and changes in indirect markers at each time-point”

- The MVCloss24-48h changes of each individual or each study?

This sentence was related to the changes reported in each study. As stated in the limitation part (page 18, L.481-482): “Firstly, the use of group values rather than individual values could limit the interpretation of the individual variability”. However, the results showed that this method allowed to characterize the time-course of commonly used indirect markers of EIMD over different levels of muscle function loss at 24-48 h post-exercise.

7. Lines 208-209: “MVC torque recovery was faster in the LOW and MOD clusters when compared with the HIGH cluster (Figure 4b).”

- In the method or Figure 4b, it was not mentioned what kind the statistical analysis was used to compare between the clusters. In Figure 4b, the significant difference between the time points and the pre-exercise level was shown. Same issue with all the other markers’ data in Figure 4&5.

We thank the reviewer for this comment, as this important information was missing in the previous version of the manuscript. We have now clarified this point in the Methods section (page 7, L.163-165): “Changes from baseline (SMD) were considered as significant when 0 was not included in the 95 % confidence interval. Similarly, SMD values were significantly different when no overlap existed between the 95 % confidence intervals of the clusters.”

8. Lines 305-306: “eccentric contractions using an isokinetic dynamometer and monoarticular exercises induced larger MVCloss 24-48h than other exercises modalities and polyarticular exercises”

- Same issue as in item#7. What are the statistical analysis data that the statement was based on?

As stated on page 7-8, L.180-184: “A Chi-square test of association was performed using Jamovi (The jamovi project (2020). jamovi (Version 1.2) [Computer Software]. Retrieved from https://www.jamovi.org, Sydney, Australia) to investigate the relationship between the level of MVCloss 24-48h (clusters) and the characteristics of participants and exercises (age, sex, training status, exercise type/modality, and muscles involved) represented by the distribution (frequencies) into each cluster (Table 1).”

This is now also clarified in the Results section (page 11, L.278-283):” The chi-square test of association showed a significant relationship between the level of MVCloss 24-48h (clusters) and the training status (p < 0.05), the exercise modality (p < 0.01) and the exercise type (p < 0.01) (Table 1). Trained participants were over-represented in the LOW cluster (44.0 %) compared to the expected value (i.e., distribution in the whole sample) (27.7 %) (Table 1a). Moreover, eccentric contractions using an isokinetic ergometer and monoarticular exercises were over-represented in the HIGH cluster compared to the expected value (56.4 % vs. 37.6 % and 64.1 vs. 47.5 %, respectively) (Table 1b and 1c).”

9. Lines 441-442: “We found that DOMS (active/passive DOMS and PPT) was poorly associated with the MVCloss 24-48h, suggesting that DOMS should not be used to evaluate the magnitude of EIMD.”

- Is this statement correct? In Table 2, active DOMS was significantly associated with MVCloss 24-48h at <6h, 48h, 72h, and >96h post-exercise, which is similar as that of ROM. So, this review is confused about the statement.

Our statements were based on the r² value which is higher for ROM at 48 h (r² = 0.52) than in active/passive DOMS (r² < 0.28). We have clarified this in the manuscript (please see page 17, L.449-453): “We found that DOMS (active/passive DOMS and PPT) was poorly associated with the MVCloss 24-48h (r² < 0.28), suggesting that DOMS may be a poor indicator of EIMD. On the contrary, a moderate correlation was found between ROM changes at 48 h post-exercise and the magnitude of MVCloss 24-48h (r² = 0.52), suggesting that ROM may be a better indicator of magnitude of EIMD at this time point.”

10. Typo in Table 2. In the first column in Table 2, RFD should be changed into “RTD”.

Thank you for picking this typo. We have modified the Table 2 as suggested by the reviewer. Now, this reads “RTD”.

11. The “n” in Table 2, Figure 2 &3 needs to be defined. Does the “n” represent the number of subjects or number of studies?

The “n” represents the number of studies in Table 2 and Figure 3 and the number of participants per experimental group in Figure 2. We have clarified this in the Table/figures legends: ““n” represents the number of studies included in the analysis.” (page 22, L.525) and ““n” represents the number of participants of the experimental group.” (page, 23, L.538).

12. What are the numbers in the parenthesis in Figure 4&5? Does each of them represent the number of the studies?

The number in parenthesis represents the number of studies. We added an explanation on page 23, L.549 and L.554-555: “The number in parenthesis represents the number of studies included in the analysis.”.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Xin Ye

27 Jun 2022

Appropriateness of indirect markers of muscle damage following lower limbs eccentric-biased exercises: A systematic review with meta-analysis

PONE-D-22-07742R1

Dear Dr. Chalchat,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Xin Ye, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: As before, I would like to commend the authors on a well-written manuscript related to an important topic. I have reviewed their responses to previous reviewer comments and the authors have provided the necessary data and scripts. At this point, I have no further changes for the manuscript.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Acceptance letter

Xin Ye

4 Jul 2022

PONE-D-22-07742R1

Appropriateness of indirect markers of muscle damage following lower limbs eccentric-biased exercises: A systematic review with meta-analysis

Dear Dr. Chalchat:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Xin Ye

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data. Quality assessment.

    (XLSM)

    S1 Fig. Schematic flowchart of study selection from initial search to the final study inclusion.

    (TIF)

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES